Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.

Authors :: Agarwal, Arnav
Xiaoxi Zeng
Sheyu Li
Rayner, Daniel
Foroutan, Farid
Aertgeerts, Bert
Coyac, Frederic
Farhoumand, Pauline Darbellay
Demaine, Andrew
Heen, Anja Fog
Jha, Vivekanand
Machuve, Edward
Nagler, Evi
Tunnicliffe, David J.
Guyatt, Gordon H.
Vandvik, Per Olav
Ponte, Belen
Agoritsas, Thomas
Source :: BMJ: British Medical Journal; 10/19/2024, Vol. 386 Issue 8445, p1-9, 9p
Publication Year :: 2024

Subjects :: MEDICAL protocols
RISK assessment
CARDIOVASCULAR diseases
TREATMENT effectiveness
CHRONIC kidney failure
SODIUM-glucose cotransporter 2 inhibitors
TYPE 2 diabetes
KIDNEY diseases
OVERALL survival
DISEASE progression
DISEASE risk factors
ADULTS

Full Text Access

Tools